ラミプリルの世界市場（～2026年）

• 英文タイトル：Global Ramipril (CAS 87333-19-5) Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY14617 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はラミプリルのグローバル市場について調査・分析したレポートです。種類別（錠剤、カプセル）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ラミプリルの競争状況、市場シェア ・世界のラミプリル市場：種類別市場規模 2015年-2020年（錠剤、カプセル） ・世界のラミプリル市場：種類別市場規模予測 2021年-2026年（錠剤、カプセル） ・世界のラミプリル市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界のラミプリル市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米のラミプリル市場分析：米国、カナダ ・ヨーロッパのラミプリル市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのラミプリル市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のラミプリル市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのラミプリル市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Arrow Pharmaceuticals、Westfield Pharma、Sanofi-Aventis、King Pharmaceuticals、Pharmanova、Santa Cruz Biotechnology、Krka、Cemelog-BRS、Hemofarm、Lek、Novartis、Opsonin Pharma Limited. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Ramipril (CAS 87333-19-5) Market
The global Ramipril (CAS 87333-19-5) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Ramipril (CAS 87333-19-5) Scope and Market Size
Ramipril (CAS 87333-19-5) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ramipril (CAS 87333-19-5) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Ramipril (CAS 87333-19-5) market is segmented into
Tablet
Capsule

Segment by Application, the Ramipril (CAS 87333-19-5) market is segmented into
Clinic
Hospital
Others

Regional and Country-level Analysis
The Ramipril (CAS 87333-19-5) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ramipril (CAS 87333-19-5) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ramipril (CAS 87333-19-5) Market Share Analysis
Ramipril (CAS 87333-19-5) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ramipril (CAS 87333-19-5) business, the date to enter into the Ramipril (CAS 87333-19-5) market, Ramipril (CAS 87333-19-5) product introduction, recent developments, etc.

The major vendors covered:
Arrow Pharmaceuticals
Westfield Pharma
Sanofi-Aventis
King Pharmaceuticals
Pharmanova
Santa Cruz Biotechnology
Krka
Cemelog-BRS
Hemofarm
Lek
Novartis
Opsonin Pharma Limited.

レポート目次

---

1 Study Coverage
1.1 Ramipril (CAS 87333-19-5) Product Introduction
1.2 Market Segments
1.3 Key Ramipril (CAS 87333-19-5) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ramipril (CAS 87333-19-5) Market Size Growth Rate by Type
1.4.2 Tablet
1.4.3 Capsule
1.5 Market by Application
1.5.1 Global Ramipril (CAS 87333-19-5) Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Ramipril (CAS 87333-19-5) Market Size, Estimates and Forecasts
2.1.1 Global Ramipril (CAS 87333-19-5) Revenue 2015-2026
2.1.2 Global Ramipril (CAS 87333-19-5) Sales 2015-2026
2.2 Global Ramipril (CAS 87333-19-5), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Ramipril (CAS 87333-19-5) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ramipril (CAS 87333-19-5) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Ramipril (CAS 87333-19-5) Competitor Landscape by Players
3.1 Ramipril (CAS 87333-19-5) Sales by Manufacturers
3.1.1 Ramipril (CAS 87333-19-5) Sales by Manufacturers (2015-2020)
3.1.2 Ramipril (CAS 87333-19-5) Sales Market Share by Manufacturers (2015-2020)
3.2 Ramipril (CAS 87333-19-5) Revenue by Manufacturers
3.2.1 Ramipril (CAS 87333-19-5) Revenue by Manufacturers (2015-2020)
3.2.2 Ramipril (CAS 87333-19-5) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ramipril (CAS 87333-19-5) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ramipril (CAS 87333-19-5) Revenue in 2019
3.2.5 Global Ramipril (CAS 87333-19-5) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ramipril (CAS 87333-19-5) Price by Manufacturers
3.4 Ramipril (CAS 87333-19-5) Manufacturing Base Distribution, Product Types
3.4.1 Ramipril (CAS 87333-19-5) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ramipril (CAS 87333-19-5) Product Type
3.4.3 Date of International Manufacturers Enter into Ramipril (CAS 87333-19-5) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Ramipril (CAS 87333-19-5) Market Size by Type (2015-2020)
4.1.1 Global Ramipril (CAS 87333-19-5) Sales by Type (2015-2020)
4.1.2 Global Ramipril (CAS 87333-19-5) Revenue by Type (2015-2020)
4.1.3 Ramipril (CAS 87333-19-5) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ramipril (CAS 87333-19-5) Market Size Forecast by Type (2021-2026)
4.2.1 Global Ramipril (CAS 87333-19-5) Sales Forecast by Type (2021-2026)
4.2.2 Global Ramipril (CAS 87333-19-5) Revenue Forecast by Type (2021-2026)
4.2.3 Ramipril (CAS 87333-19-5) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ramipril (CAS 87333-19-5) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Ramipril (CAS 87333-19-5) Market Size by Application (2015-2020)
5.1.1 Global Ramipril (CAS 87333-19-5) Sales by Application (2015-2020)
5.1.2 Global Ramipril (CAS 87333-19-5) Revenue by Application (2015-2020)
5.1.3 Ramipril (CAS 87333-19-5) Price by Application (2015-2020)
5.2 Ramipril (CAS 87333-19-5) Market Size Forecast by Application (2021-2026)
5.2.1 Global Ramipril (CAS 87333-19-5) Sales Forecast by Application (2021-2026)
5.2.2 Global Ramipril (CAS 87333-19-5) Revenue Forecast by Application (2021-2026)
5.2.3 Global Ramipril (CAS 87333-19-5) Price Forecast by Application (2021-2026)

6 North America
6.1 North America Ramipril (CAS 87333-19-5) by Country
6.1.1 North America Ramipril (CAS 87333-19-5) Sales by Country
6.1.2 North America Ramipril (CAS 87333-19-5) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ramipril (CAS 87333-19-5) Market Facts & Figures by Type
6.3 North America Ramipril (CAS 87333-19-5) Market Facts & Figures by Application

7 Europe
7.1 Europe Ramipril (CAS 87333-19-5) by Country
7.1.1 Europe Ramipril (CAS 87333-19-5) Sales by Country
7.1.2 Europe Ramipril (CAS 87333-19-5) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ramipril (CAS 87333-19-5) Market Facts & Figures by Type
7.3 Europe Ramipril (CAS 87333-19-5) Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Ramipril (CAS 87333-19-5) by Region
8.1.1 Asia Pacific Ramipril (CAS 87333-19-5) Sales by Region
8.1.2 Asia Pacific Ramipril (CAS 87333-19-5) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ramipril (CAS 87333-19-5) Market Facts & Figures by Type
8.3 Asia Pacific Ramipril (CAS 87333-19-5) Market Facts & Figures by Application

9 Latin America
9.1 Latin America Ramipril (CAS 87333-19-5) by Country
9.1.1 Latin America Ramipril (CAS 87333-19-5) Sales by Country
9.1.2 Latin America Ramipril (CAS 87333-19-5) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ramipril (CAS 87333-19-5) Market Facts & Figures by Type
9.3 Central & South America Ramipril (CAS 87333-19-5) Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Ramipril (CAS 87333-19-5) by Country
10.1.1 Middle East and Africa Ramipril (CAS 87333-19-5) Sales by Country
10.1.2 Middle East and Africa Ramipril (CAS 87333-19-5) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ramipril (CAS 87333-19-5) Market Facts & Figures by Type
10.3 Middle East and Africa Ramipril (CAS 87333-19-5) Market Facts & Figures by Application

11 Company Profiles
11.1 Arrow Pharmaceuticals
11.1.1 Arrow Pharmaceuticals Corporation Information
11.1.2 Arrow Pharmaceuticals Description and Business Overview
11.1.3 Arrow Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Arrow Pharmaceuticals Ramipril (CAS 87333-19-5) Products Offered
11.1.5 Arrow Pharmaceuticals Related Developments
11.2 Westfield Pharma
11.2.1 Westfield Pharma Corporation Information
11.2.2 Westfield Pharma Description and Business Overview
11.2.3 Westfield Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Westfield Pharma Ramipril (CAS 87333-19-5) Products Offered
11.2.5 Westfield Pharma Related Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Corporation Information
11.3.2 Sanofi-Aventis Description and Business Overview
11.3.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi-Aventis Ramipril (CAS 87333-19-5) Products Offered
11.3.5 Sanofi-Aventis Related Developments
11.4 King Pharmaceuticals
11.4.1 King Pharmaceuticals Corporation Information
11.4.2 King Pharmaceuticals Description and Business Overview
11.4.3 King Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 King Pharmaceuticals Ramipril (CAS 87333-19-5) Products Offered
11.4.5 King Pharmaceuticals Related Developments
11.5 Pharmanova
11.5.1 Pharmanova Corporation Information
11.5.2 Pharmanova Description and Business Overview
11.5.3 Pharmanova Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pharmanova Ramipril (CAS 87333-19-5) Products Offered
11.5.5 Pharmanova Related Developments
11.6 Santa Cruz Biotechnology
11.6.1 Santa Cruz Biotechnology Corporation Information
11.6.2 Santa Cruz Biotechnology Description and Business Overview
11.6.3 Santa Cruz Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Santa Cruz Biotechnology Ramipril (CAS 87333-19-5) Products Offered
11.6.5 Santa Cruz Biotechnology Related Developments
11.7 Krka
11.7.1 Krka Corporation Information
11.7.2 Krka Description and Business Overview
11.7.3 Krka Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Krka Ramipril (CAS 87333-19-5) Products Offered
11.7.5 Krka Related Developments
11.8 Cemelog-BRS
11.8.1 Cemelog-BRS Corporation Information
11.8.2 Cemelog-BRS Description and Business Overview
11.8.3 Cemelog-BRS Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Cemelog-BRS Ramipril (CAS 87333-19-5) Products Offered
11.8.5 Cemelog-BRS Related Developments
11.9 Hemofarm
11.9.1 Hemofarm Corporation Information
11.9.2 Hemofarm Description and Business Overview
11.9.3 Hemofarm Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hemofarm Ramipril (CAS 87333-19-5) Products Offered
11.9.5 Hemofarm Related Developments
11.10 Lek
11.10.1 Lek Corporation Information
11.10.2 Lek Description and Business Overview
11.10.3 Lek Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lek Ramipril (CAS 87333-19-5) Products Offered
11.10.5 Lek Related Developments
11.1 Arrow Pharmaceuticals
11.1.1 Arrow Pharmaceuticals Corporation Information
11.1.2 Arrow Pharmaceuticals Description and Business Overview
11.1.3 Arrow Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Arrow Pharmaceuticals Ramipril (CAS 87333-19-5) Products Offered
11.1.5 Arrow Pharmaceuticals Related Developments
11.12 Opsonin Pharma Limited.
11.12.1 Opsonin Pharma Limited. Corporation Information
11.12.2 Opsonin Pharma Limited. Description and Business Overview
11.12.3 Opsonin Pharma Limited. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Opsonin Pharma Limited. Products Offered
11.12.5 Opsonin Pharma Limited. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Ramipril (CAS 87333-19-5) Market Estimates and Projections by Region
12.1.1 Global Ramipril (CAS 87333-19-5) Sales Forecast by Regions 2021-2026
12.1.2 Global Ramipril (CAS 87333-19-5) Revenue Forecast by Regions 2021-2026
12.2 North America Ramipril (CAS 87333-19-5) Market Size Forecast (2021-2026)
12.2.1 North America: Ramipril (CAS 87333-19-5) Sales Forecast (2021-2026)
12.2.2 North America: Ramipril (CAS 87333-19-5) Revenue Forecast (2021-2026)
12.2.3 North America: Ramipril (CAS 87333-19-5) Market Size Forecast by Country (2021-2026)
12.3 Europe Ramipril (CAS 87333-19-5) Market Size Forecast (2021-2026)
12.3.1 Europe: Ramipril (CAS 87333-19-5) Sales Forecast (2021-2026)
12.3.2 Europe: Ramipril (CAS 87333-19-5) Revenue Forecast (2021-2026)
12.3.3 Europe: Ramipril (CAS 87333-19-5) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ramipril (CAS 87333-19-5) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ramipril (CAS 87333-19-5) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ramipril (CAS 87333-19-5) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ramipril (CAS 87333-19-5) Market Size Forecast by Region (2021-2026)
12.5 Latin America Ramipril (CAS 87333-19-5) Market Size Forecast (2021-2026)
12.5.1 Latin America: Ramipril (CAS 87333-19-5) Sales Forecast (2021-2026)
12.5.2 Latin America: Ramipril (CAS 87333-19-5) Revenue Forecast (2021-2026)
12.5.3 Latin America: Ramipril (CAS 87333-19-5) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ramipril (CAS 87333-19-5) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ramipril (CAS 87333-19-5) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ramipril (CAS 87333-19-5) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ramipril (CAS 87333-19-5) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ramipril (CAS 87333-19-5) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ramipril (CAS 87333-19-5) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Ramipril (CAS 87333-19-5) Market Segments
Table 2. Ranking of Global Top Ramipril (CAS 87333-19-5) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ramipril (CAS 87333-19-5) Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Tablet
Table 5. Major Manufacturers of Capsule
Table 6. Global Ramipril (CAS 87333-19-5) Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Ramipril (CAS 87333-19-5) Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Ramipril (CAS 87333-19-5) Sales by Regions 2015-2020 (K Units)
Table 9. Global Ramipril (CAS 87333-19-5) Sales Market Share by Regions (2015-2020)
Table 10. Global Ramipril (CAS 87333-19-5) Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Ramipril (CAS 87333-19-5) Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Ramipril (CAS 87333-19-5) Sales Share by Manufacturers (2015-2020)
Table 13. Global Ramipril (CAS 87333-19-5) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Ramipril (CAS 87333-19-5) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ramipril (CAS 87333-19-5) as of 2019)
Table 15. Ramipril (CAS 87333-19-5) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Ramipril (CAS 87333-19-5) Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Ramipril (CAS 87333-19-5) Price (2015-2020) (USD/Unit)
Table 18. Ramipril (CAS 87333-19-5) Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Ramipril (CAS 87333-19-5) Product Type
Table 20. Date of International Manufacturers Enter into Ramipril (CAS 87333-19-5) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Ramipril (CAS 87333-19-5) Sales by Type (2015-2020) (K Units)
Table 23. Global Ramipril (CAS 87333-19-5) Sales Share by Type (2015-2020)
Table 24. Global Ramipril (CAS 87333-19-5) Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Ramipril (CAS 87333-19-5) Revenue Share by Type (2015-2020)
Table 26. Ramipril (CAS 87333-19-5) Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Ramipril (CAS 87333-19-5) Sales by Application (2015-2020) (K Units)
Table 28. Global Ramipril (CAS 87333-19-5) Sales Share by Application (2015-2020)
Table 29. North America Ramipril (CAS 87333-19-5) Sales by Country (2015-2020) (K Units)
Table 30. North America Ramipril (CAS 87333-19-5) Sales Market Share by Country (2015-2020)
Table 31. North America Ramipril (CAS 87333-19-5) Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Ramipril (CAS 87333-19-5) Revenue Market Share by Country (2015-2020)
Table 33. North America Ramipril (CAS 87333-19-5) Sales by Type (2015-2020) (K Units)
Table 34. North America Ramipril (CAS 87333-19-5) Sales Market Share by Type (2015-2020)
Table 35. North America Ramipril (CAS 87333-19-5) Sales by Application (2015-2020) (K Units)
Table 36. North America Ramipril (CAS 87333-19-5) Sales Market Share by Application (2015-2020)
Table 37. Europe Ramipril (CAS 87333-19-5) Sales by Country (2015-2020) (K Units)
Table 38. Europe Ramipril (CAS 87333-19-5) Sales Market Share by Country (2015-2020)
Table 39. Europe Ramipril (CAS 87333-19-5) Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Ramipril (CAS 87333-19-5) Revenue Market Share by Country (2015-2020)
Table 41. Europe Ramipril (CAS 87333-19-5) Sales by Type (2015-2020) (K Units)
Table 42. Europe Ramipril (CAS 87333-19-5) Sales Market Share by Type (2015-2020)
Table 43. Europe Ramipril (CAS 87333-19-5) Sales by Application (2015-2020) (K Units)
Table 44. Europe Ramipril (CAS 87333-19-5) Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Ramipril (CAS 87333-19-5) Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Ramipril (CAS 87333-19-5) Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Ramipril (CAS 87333-19-5) Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Ramipril (CAS 87333-19-5) Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Ramipril (CAS 87333-19-5) Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Ramipril (CAS 87333-19-5) Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Ramipril (CAS 87333-19-5) Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Ramipril (CAS 87333-19-5) Sales Market Share by Application (2015-2020)
Table 53. Latin America Ramipril (CAS 87333-19-5) Sales by Country (2015-2020) (K Units)
Table 54. Latin America Ramipril (CAS 87333-19-5) Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Ramipril (CAS 87333-19-5) Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Ramipril (CAS 87333-19-5) Revenue Market Share by Country (2015-2020)
Table 57. Latin America Ramipril (CAS 87333-19-5) Sales by Type (2015-2020) (K Units)
Table 58. Latin America Ramipril (CAS 87333-19-5) Sales Market Share by Type (2015-2020)
Table 59. Latin America Ramipril (CAS 87333-19-5) Sales by Application (2015-2020) (K Units)
Table 60. Latin America Ramipril (CAS 87333-19-5) Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Ramipril (CAS 87333-19-5) Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Ramipril (CAS 87333-19-5) Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Ramipril (CAS 87333-19-5) Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Ramipril (CAS 87333-19-5) Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Ramipril (CAS 87333-19-5) Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Ramipril (CAS 87333-19-5) Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Ramipril (CAS 87333-19-5) Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Ramipril (CAS 87333-19-5) Sales Market Share by Application (2015-2020)
Table 69. Arrow Pharmaceuticals Corporation Information
Table 70. Arrow Pharmaceuticals Description and Major Businesses
Table 71. Arrow Pharmaceuticals Ramipril (CAS 87333-19-5) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Arrow Pharmaceuticals Product
Table 73. Arrow Pharmaceuticals Recent Development
Table 74. Westfield Pharma Corporation Information
Table 75. Westfield Pharma Description and Major Businesses
Table 76. Westfield Pharma Ramipril (CAS 87333-19-5) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Westfield Pharma Product
Table 78. Westfield Pharma Recent Development
Table 79. Sanofi-Aventis Corporation Information
Table 80. Sanofi-Aventis Description and Major Businesses
Table 81. Sanofi-Aventis Ramipril (CAS 87333-19-5) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Sanofi-Aventis Product
Table 83. Sanofi-Aventis Recent Development
Table 84. King Pharmaceuticals Corporation Information
Table 85. King Pharmaceuticals Description and Major Businesses
Table 86. King Pharmaceuticals Ramipril (CAS 87333-19-5) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. King Pharmaceuticals Product
Table 88. King Pharmaceuticals Recent Development
Table 89. Pharmanova Corporation Information
Table 90. Pharmanova Description and Major Businesses
Table 91. Pharmanova Ramipril (CAS 87333-19-5) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Pharmanova Product
Table 93. Pharmanova Recent Development
Table 94. Santa Cruz Biotechnology Corporation Information
Table 95. Santa Cruz Biotechnology Description and Major Businesses
Table 96. Santa Cruz Biotechnology Ramipril (CAS 87333-19-5) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Santa Cruz Biotechnology Product
Table 98. Santa Cruz Biotechnology Recent Development
Table 99. Krka Corporation Information
Table 100. Krka Description and Major Businesses
Table 101. Krka Ramipril (CAS 87333-19-5) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Krka Product
Table 103. Krka Recent Development
Table 104. Cemelog-BRS Corporation Information
Table 105. Cemelog-BRS Description and Major Businesses
Table 106. Cemelog-BRS Ramipril (CAS 87333-19-5) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Cemelog-BRS Product
Table 108. Cemelog-BRS Recent Development
Table 109. Hemofarm Corporation Information
Table 110. Hemofarm Description and Major Businesses
Table 111. Hemofarm Ramipril (CAS 87333-19-5) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Hemofarm Product
Table 113. Hemofarm Recent Development
Table 114. Lek Corporation Information
Table 115. Lek Description and Major Businesses
Table 116. Lek Ramipril (CAS 87333-19-5) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Lek Product
Table 118. Lek Recent Development
Table 119. Novartis Corporation Information
Table 120. Novartis Description and Major Businesses
Table 121. Novartis Ramipril (CAS 87333-19-5) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Novartis Product
Table 123. Novartis Recent Development
Table 124. Opsonin Pharma Limited. Corporation Information
Table 125. Opsonin Pharma Limited. Description and Major Businesses
Table 126. Opsonin Pharma Limited. Ramipril (CAS 87333-19-5) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Opsonin Pharma Limited. Product
Table 128. Opsonin Pharma Limited. Recent Development
Table 129. Global Ramipril (CAS 87333-19-5) Sales Forecast by Regions (2021-2026) (K Units)
Table 130. Global Ramipril (CAS 87333-19-5) Sales Market Share Forecast by Regions (2021-2026)
Table 131. Global Ramipril (CAS 87333-19-5) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 132. Global Ramipril (CAS 87333-19-5) Revenue Market Share Forecast by Regions (2021-2026)
Table 133. North America: Ramipril (CAS 87333-19-5) Sales Forecast by Country (2021-2026) (K Units)
Table 134. North America: Ramipril (CAS 87333-19-5) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Europe: Ramipril (CAS 87333-19-5) Sales Forecast by Country (2021-2026) (K Units)
Table 136. Europe: Ramipril (CAS 87333-19-5) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Asia Pacific: Ramipril (CAS 87333-19-5) Sales Forecast by Region (2021-2026) (K Units)
Table 138. Asia Pacific: Ramipril (CAS 87333-19-5) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Latin America: Ramipril (CAS 87333-19-5) Sales Forecast by Country (2021-2026) (K Units)
Table 140. Latin America: Ramipril (CAS 87333-19-5) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Middle East and Africa: Ramipril (CAS 87333-19-5) Sales Forecast by Country (2021-2026) (K Units)
Table 142. Middle East and Africa: Ramipril (CAS 87333-19-5) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Market Risks
Table 146. Main Points Interviewed from Key Ramipril (CAS 87333-19-5) Players
Table 147. Ramipril (CAS 87333-19-5) Customers List
Table 148. Ramipril (CAS 87333-19-5) Distributors List
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Ramipril (CAS 87333-19-5) Product Picture
Figure 2. Global Ramipril (CAS 87333-19-5) Sales Market Share by Type in 2020 & 2026
Figure 3. Tablet Product Picture
Figure 4. Capsule Product Picture
Figure 5. Global Ramipril (CAS 87333-19-5) Sales Market Share by Application in 2020 & 2026
Figure 6. Clinic
Figure 7. Hospital
Figure 8. Others
Figure 9. Ramipril (CAS 87333-19-5) Report Years Considered
Figure 10. Global Ramipril (CAS 87333-19-5) Market Size 2015-2026 (US$ Million)
Figure 11. Global Ramipril (CAS 87333-19-5) Sales 2015-2026 (K Units)
Figure 12. Global Ramipril (CAS 87333-19-5) Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Ramipril (CAS 87333-19-5) Sales Market Share by Region (2015-2020)
Figure 14. Global Ramipril (CAS 87333-19-5) Sales Market Share by Region in 2019
Figure 15. Global Ramipril (CAS 87333-19-5) Revenue Market Share by Region (2015-2020)
Figure 16. Global Ramipril (CAS 87333-19-5) Revenue Market Share by Region in 2019
Figure 17. Global Ramipril (CAS 87333-19-5) Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Ramipril (CAS 87333-19-5) Revenue in 2019
Figure 19. Ramipril (CAS 87333-19-5) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Ramipril (CAS 87333-19-5) Sales Market Share by Type (2015-2020)
Figure 21. Global Ramipril (CAS 87333-19-5) Sales Market Share by Type in 2019
Figure 22. Global Ramipril (CAS 87333-19-5) Revenue Market Share by Type (2015-2020)
Figure 23. Global Ramipril (CAS 87333-19-5) Revenue Market Share by Type in 2019
Figure 24. Global Ramipril (CAS 87333-19-5) Market Share by Price Range (2015-2020)
Figure 25. Global Ramipril (CAS 87333-19-5) Sales Market Share by Application (2015-2020)
Figure 26. Global Ramipril (CAS 87333-19-5) Sales Market Share by Application in 2019
Figure 27. Global Ramipril (CAS 87333-19-5) Revenue Market Share by Application (2015-2020)
Figure 28. Global Ramipril (CAS 87333-19-5) Revenue Market Share by Application in 2019
Figure 29. North America Ramipril (CAS 87333-19-5) Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Ramipril (CAS 87333-19-5) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Ramipril (CAS 87333-19-5) Sales Market Share by Country in 2019
Figure 32. North America Ramipril (CAS 87333-19-5) Revenue Market Share by Country in 2019
Figure 33. U.S. Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Ramipril (CAS 87333-19-5) Market Share by Type in 2019
Figure 38. North America Ramipril (CAS 87333-19-5) Market Share by Application in 2019
Figure 39. Europe Ramipril (CAS 87333-19-5) Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Ramipril (CAS 87333-19-5) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Ramipril (CAS 87333-19-5) Sales Market Share by Country in 2019
Figure 42. Europe Ramipril (CAS 87333-19-5) Revenue Market Share by Country in 2019
Figure 43. Germany Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Ramipril (CAS 87333-19-5) Market Share by Type in 2019
Figure 54. Europe Ramipril (CAS 87333-19-5) Market Share by Application in 2019
Figure 55. Asia Pacific Ramipril (CAS 87333-19-5) Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Ramipril (CAS 87333-19-5) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Ramipril (CAS 87333-19-5) Sales Market Share by Region in 2019
Figure 58. Asia Pacific Ramipril (CAS 87333-19-5) Revenue Market Share by Region in 2019
Figure 59. China Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Ramipril (CAS 87333-19-5) Market Share by Type in 2019
Figure 82. Asia Pacific Ramipril (CAS 87333-19-5) Market Share by Application in 2019
Figure 83. Latin America Ramipril (CAS 87333-19-5) Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Ramipril (CAS 87333-19-5) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Ramipril (CAS 87333-19-5) Sales Market Share by Country in 2019
Figure 86. Latin America Ramipril (CAS 87333-19-5) Revenue Market Share by Country in 2019
Figure 87. Mexico Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Ramipril (CAS 87333-19-5) Market Share by Type in 2019
Figure 94. Latin America Ramipril (CAS 87333-19-5) Market Share by Application in 2019
Figure 95. Middle East and Africa Ramipril (CAS 87333-19-5) Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Ramipril (CAS 87333-19-5) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Ramipril (CAS 87333-19-5) Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Ramipril (CAS 87333-19-5) Revenue Market Share by Country in 2019
Figure 99. Turkey Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Ramipril (CAS 87333-19-5) Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Ramipril (CAS 87333-19-5) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Ramipril (CAS 87333-19-5) Market Share by Type in 2019
Figure 106. Middle East and Africa Ramipril (CAS 87333-19-5) Market Share by Application in 2019
Figure 107. North America Ramipril (CAS 87333-19-5) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Ramipril (CAS 87333-19-5) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Ramipril (CAS 87333-19-5) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Ramipril (CAS 87333-19-5) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Ramipril (CAS 87333-19-5) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Ramipril (CAS 87333-19-5) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Ramipril (CAS 87333-19-5) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Ramipril (CAS 87333-19-5) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Ramipril (CAS 87333-19-5) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Ramipril (CAS 87333-19-5) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed

---